CHRS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.705 USD -0.29% Market Closed

Market Cap: $255.6m

	Coherus BioSciences Inc NASDAQ:CHRS	US
	Luceco PLC LSE:LUCE	UK
	Cordel Group PLC LSE:CRDL	UK
	Assicurazioni Generali SpA MIL:G	IT
B	Bank CIMB Niaga Tbk PT IDX:BNGA	ID

Profitability Summary

Coherus BioSciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

52%

Gross Margin is Increasing

58% > 67%

Negative Operating Margin

-410%

Negative 3Y Average Operating Margin

-173%

Declining Operating Margin

-130% > -410%

Exceptional Net Margin

398%

Strong 3Y Average Net Margin

35%

Net Margin is Increasing

-148% > 398%

Negative Free Cash Flow Margin

-328%

Negative 3Y Average Free Cash Flow Margin

-91%

Declining Free Cash Flow Margin

-140% > -328%

Negative ROE

-473%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-52%

ROIC is Increasing

-96% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.